Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation (AF) is a prevalent cardiac arrhythmia characterized by irregular and frequently rapid electrical activity in the atria.
Cell therapy commercialization: Streamline your path to cell therapy commercialization
Moving your cell therapy clinical trial beyond Phase I is an exciting time, marking a significant milestone. There are many therapeutic developers working to address